MicroMed and Chrysalis cardiovascular deal

MicroMed (Houston, Texas) will evaluate the effectiveness of Chrysalin, a synthetic thrombin mimic developed by Chrysalis BioTechnology (Galveston, Texas), to promote the regeneration of blood vessels...